To test this hypothesis we assessed cell viability, IRP mRNA binding activity, and iron-mediated lipid peroxidation following erastin induction in isogenic cell lines expressing inducible versions of the six most commonly observed TP53 mutations in human cancers. The gene discussed is TP53; the disease is cancer.